Pharma & Biotech

The European Lung Cancer Congress in Copenhagen, which opens today, serves as a critical platform for BioNTech to showcase its...

A recent clinical trial update from Ocugen has prompted a significant reassessment of the company's prospects among Wall Street analysts....

The pharmaceutical landscape for weight-loss medications is transforming into a fiercely competitive battleground. Recent clinical advancements from Danish rival Novo...

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant corporate milestone announced...

In a counterintuitive market reaction, Ocugen's stock price declined significantly following the announcement of encouraging 12-month data from its Phase...

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off in ImmunityBio shares....

A surge in institutional buying activity is placing a traditional healthcare conglomerate firmly on the radar of major market players....

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical company faces a...

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational improvements but also...

As Humacyte prepares to release its full-year 2025 financial results, the biotechnology firm finds its stock trading at a historic...